Evidence map›Paper›PMID 40404259›Full record

ArticleKidney international2025

Osteocytes burn out, give bone a break.

Aline Martin

Abstract read
In one paragraph

Article in Kidney international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Aline MartinCenter for Translational Metabolism and Health, Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago Illinois, USA. Electronic address: aline.martin@northwestern.edu.

Funding

Role of FGF23 and Phosphate in Chronic Kidney DiseaseR01DK131046 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MARTIN, ALINE C · 2022 to 2025
$2.5M
The role of DMP1 in FGF23-induced hypophosphatemiaR01DK132342 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MARTIN, ALINE C · 2022 to 2025
$2.3M
NIDDK NIH HHS R01 DK131046NIDDK NIH HHS R01 DK132342
6 · The paper itself

Abstract

The pathogenic mechanisms of chronic kidney disease-induced osteoporosis are not well understood and might involve metabolic alterations and apoptosis of osteocytes. In this issue, Hsu et al. present experimental work in uremic mice and cultured mouse osteoblasts showing that impaired mitochondrial function and mitophagy in osteocytes contribute to chronic kidney disease-associated osteoporosis. They investigate new therapeutic approaches to improve mitochondrial function in the setting of increased uremic toxin levels.

Indexed as

MitophagyOsteocytesOsteoporosisRenal Insufficiency, ChronicAnimalsHumansMiceMitochondriaOsteoblastsUremia

Identifiers

PMID40404259
PMCPMC12889302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.